Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ETWONYSE:EVHNASDAQ:IIINASDAQ:UXIN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeETWOE2open Parent$3.21+0.2%$2.28$1.75▼$4.82$1.10B1.042.75 million shs21.07 million shsEVHEvolent Health$7.33-4.1%$9.29$7.06▼$33.63$859.96M1.042.42 million shs955,511 shsIIIInformation Services Group$4.68$4.02$2.92▼$5.05$225.60M1.08114,942 shs106,474 shsUXINUxin$4.38+0.5%$4.30$1.41▼$7.84$823.38M1.37527,120 shs12,459 shs The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceETWOE2open Parent+0.31%+20.90%+52.86%+40.48%-32.77%EVHEvolent Health-0.52%-4.67%-17.83%-11.82%-66.87%IIIInformation Services Group-3.11%-1.68%+27.87%+52.44%+48.57%UXINUxin-1.58%-3.96%-5.01%-4.60%+90.39%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationETWOE2open Parent1.6007 of 5 stars0.95.00.00.02.00.82.5EVHEvolent Health3.0125 of 5 stars4.52.00.00.02.21.70.6IIIInformation Services Group3.074 of 5 stars2.54.01.70.01.42.51.9UXINUxin0.9478 of 5 stars0.04.00.00.03.01.70.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceETWOE2open Parent 1.75Reduce$2.78-13.42% DownsideEVHEvolent Health 3.00Buy$17.79142.81% UpsideIIIInformation Services Group 3.00Buy$5.5017.52% UpsideUXINUxin 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest III, ETWO, UXIN, and EVH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/28/2025ETWOE2open ParentMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$2.10 ➝ $3.305/13/2025EVHEvolent HealthNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$15.00 ➝ $15.005/12/2025IIIInformation Services GroupSidotiSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold5/12/2025IIIInformation Services GroupBarrington ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$3.75 ➝ $5.505/9/2025EVHEvolent HealthUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$14.00 ➝ $15.004/30/2025ETWOE2open ParentUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$3.00 ➝ $2.504/28/2025EVHEvolent HealthJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$13.00 ➝ $13.004/16/2025ETWOE2open ParentMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$3.00 ➝ $2.304/10/2025EVHEvolent HealthTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$15.00 ➝ $14.003/28/2025ETWOE2open ParentThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetSell ➝ Sell$2.60 ➝ $2.303/10/2025EVHEvolent HealthJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$13.00 ➝ $12.00(Data available from 5/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookETWOE2open Parent$607.69M1.81$5.43 per share0.59$4.65 per share0.69EVHEvolent Health$2.40B0.36$1.22 per share6.00$9.38 per share0.78IIIInformation Services Group$242.90M0.93$0.60 per share7.83$2.09 per share2.24UXINUxin$1.63B0.51$1.25 per share3.50($0.22) per share-19.91Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateETWOE2open Parent-$1.07B-$2.14N/A14.571.05-74.63%4.38%2.12%7/9/2025 (Estimated)EVHEvolent Health-$113.04M-$1.23N/AN/AN/A-2.41%5.73%2.36%8/14/2025 (Estimated)IIIInformation Services Group$6.15M$0.15N/A29.251.34-1.20%4.43%1.83%8/4/2025 (Estimated)UXINUxin-$51.58M-$18.08N/A∞N/A-20.57%-248.43%73.24%N/ALatest III, ETWO, UXIN, and EVH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025EVHEvolent Health$0.08$0.06-$0.02-$0.63$460.15 million$483.65 million4/30/2025Q4 2025UXINUxinN/A-$0.03N/A-$0.07N/A$81.76 million4/29/2025Q4 2025ETWOE2open Parent$0.05$0.06+$0.01-$0.79$153.01 million$153.50 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthETWOE2open ParentN/AN/AN/AN/AN/AEVHEvolent HealthN/AN/AN/AN/AN/AIIIInformation Services Group$0.183.85%+25.99%120.00%1 YearsUXINUxinN/AN/AN/AN/AN/ALatest III, ETWO, UXIN, and EVH DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/6/2025IIIInformation Services Groupquarterly$0.04503.9%6/6/20256/6/20256/27/20253/4/2025IIIInformation Services Groupquarterly$0.04505.6%3/21/20253/21/20253/28/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioETWOE2open Parent0.911.081.08EVHEvolent Health0.581.041.04IIIInformation Services Group0.691.971.97UXINUxinN/A0.440.19Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipETWOE2open ParentN/AEVHEvolent HealthN/AIIIInformation Services Group73.10%UXINUxin22.41%Insider OwnershipCompanyInsider OwnershipETWOE2open Parent4.70%EVHEvolent Health1.60%IIIInformation Services Group15.90%UXINUxin62.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableETWOE2open Parent3,680343.99 million327.11 millionOptionableEVHEvolent Health5,100117.40 million114.70 millionOptionableIIIInformation Services Group1,34048.20 million41.22 millionNot OptionableUXINUxin810187.99 million69.68 millionOptionableIII, ETWO, UXIN, and EVH HeadlinesRecent News About These CompaniesUxin (NASDAQ:UXIN) Shares Gap Up - Still a Buy?May 23, 2025 | marketbeat.comA plant hormone's secret passage: Researchers elucidate molecular mechanism of auxin influxMay 15, 2025 | msn.comUxin (NASDAQ:UXIN) Trading Up 6.1% - What's Next?May 15, 2025 | marketbeat.comUxin Full Year 2024 Earnings: CN¥2.39 loss per share (vs CN¥64.67 loss in FY 2023)May 2, 2025 | finance.yahoo.comUxin (NASDAQ:UXIN) Shares Down 5.4% - Time to Sell?May 1, 2025 | marketbeat.comUxin Ltd (UXIN) Q4 2024 Earnings Call Highlights: Record Growth and Positive EBITDA Mark a ...May 1, 2025 | finance.yahoo.comUxin Reports Strong Growth and Expansion Plans Amidst Economic ChallengesApril 30, 2025 | tipranks.comUxin Full Year 2024 Annual Letter to ShareholdersApril 30, 2025 | prnewswire.comUxin Reports Unaudited Financial Results for the Quarter and Full Year Ended December 31, 2024April 30, 2025 | prnewswire.comUxin to Report Fourth Quarter and Full Year 2024 Financial Results on April 30, 2025April 23, 2025 | prnewswire.comAsian Equities Traded in the US as American Depositary Receipts Surge in Thursday TradingApril 17, 2025 | msn.comDida Inc. Completes Share Subscription in Uxin LimitedApril 9, 2025 | tipranks.comAsian Equities Traded in the US as American Depositary Receipts Rebound Strongly in Tuesday TradingApril 8, 2025 | msn.comUxin: Why Its Future Is Still Up In The AirMarch 27, 2025 | seekingalpha.comUxin: Why Its Future Is Still Up In The AirMarch 27, 2025 | seekingalpha.comUxin sells $27.88M shares to Fame Dragon GlobalMarch 5, 2025 | markets.businessinsider.comUxin Secures $27.9 Million Investment from NIO CapitalMarch 5, 2025 | tipranks.comUxin Announces Entry into Definitive Agreements for FinancingMarch 5, 2025 | prnewswire.comPrivate equity firms account for 49% of Uxin Limited's (NASDAQ:UXIN) ownership, while insiders account for 35%February 16, 2025 | finance.yahoo.comUxin Ltd Uxin LtdDecember 12, 2024 | morningstar.comCATL, Uxin to co-develop battery swapping solution for used carsDecember 3, 2024 | news.metal.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesBullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsBy Thomas Hughes | May 27, 2025View Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsNavitas Soars on NVIDIA Deal: Breaking Down Its Tech and OutlookBy Leo Miller | May 27, 2025View Navitas Soars on NVIDIA Deal: Breaking Down Its Tech and OutlookPalo Alto Networks: Buy The Dip, Long-Term Tailwinds AheadBy Thomas Hughes | May 21, 2025View Palo Alto Networks: Buy The Dip, Long-Term Tailwinds Ahead3 Stocks Plan +$130B in Buybacks: Why Markets Wanted Even MoreBy Leo Miller | May 13, 2025View 3 Stocks Plan +$130B in Buybacks: Why Markets Wanted Even MoreIntel's Loss Is Broadcom's Gain as AVGO Dominates NetworkingBy Leo Miller | May 29, 2025View Intel's Loss Is Broadcom's Gain as AVGO Dominates NetworkingIII, ETWO, UXIN, and EVH Company DescriptionsE2open Parent NYSE:ETWO$3.20 +0.01 (+0.16%) Closing price 03:59 PM EasternExtended Trading$3.20 0.00 (0.00%) As of 06:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.E2open Parent Holdings, Inc. provides cloud-based and end-to-end supply chain management and orchestration SaaS platform in the Americas, Europe, and the Asia Pacific. Its SaaS platform includes various key strategic and operational areas, including omni-channel, demand sensing, supply planning, global trade management, transportation and logistics and manufacturing and supply management. The company's software combines networks, data, and applications to provide a deeply embedded and mission-critical platform that allows its clients to optimize their channel and supply chains. It serves consumer goods, food and beverage, manufacturing, retail, industrial and automotive, aerospace and defense, technology and transportation, and other industries. The company was incorporated in 2020 and is headquartered in Austin, Texas.Evolent Health NYSE:EVH$7.32 -0.32 (-4.12%) Closing price 03:59 PM EasternExtended Trading$7.51 +0.19 (+2.53%) As of 07:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.Information Services Group NASDAQ:III$4.68 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$4.68 +0.00 (+0.11%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Information Services Group, Inc., together with its subsidiaries, operates as a technology research and advisory company in the Americas, Europe, and the Asia Pacific. The company offers digital transformation services, including automation, cloud, and data analytics; sourcing advisory; managed governance and risk; network carrier; technology strategy and operations design; change management; and market intelligence and technology research and analysis services. It supports private and public sector organizations to transform and optimize their operational environments. The company also provides ISG Digital, a client solution platform that helps clients developing technology, transformation, sourcing, and digital solutions; and ISG Enterprise, a client solution platform that helps clients manage change and optimize operations in areas comprising finance, human resource, and Procure2Pay. In addition, it offers ISG GovernX to automate the management of third-party supplier relationships that comprise contract and project lifecycles, and risk management; ISG Generative AI; ISG Network Select to streamline and simplify how enterprises build their network solutions; HR technology and transformations; providers-as-a-business services; ISG Digital Engineering; ISG Research; and training-as-a-service. The company serves private sector clients operating in the manufacturing, banking and financial services, insurance, health sciences, energy and utilities, and consumer services industries; and public sector clients, including state and local governments, airport and transit authorities, and national and provincial government units. Information Services Group, Inc. was founded in 2006 and is based in Stamford, Connecticut.Uxin NASDAQ:UXIN$4.38 +0.02 (+0.46%) Closing price 03:59 PM EasternExtended Trading$4.27 -0.11 (-2.51%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Uxin Limited, an investment holding company, engages in the retail sale of vehicles in China. The company operates an e-commerce platform for buying and selling used cars. It also offers used-car acquisition, inspection, reconditioning, warehousing, pre-sales and after-sales, and various car-related value-added products and services, as well as warranty and repair, delivery, and title transfers and vehicle registration services. Uxin Limited was incorporated in 2011 and is headquartered in Beijing, China. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Hormel Stock Near Lows, But Tariff Relief Could Boost Outlook Salesforce’s Stock Price Presents an Opportunity to Buy NVIDIA Will Set a New High Soon, Then Keep Rallying, Here’s Why Goodyear Stock Surges 28% in 2025: Is More Growth Ahead? Intel's Loss Is Broadcom's Gain as AVGO Dominates Networking Target's Big Bet: Is It a Cheap Stock or a Value Trap? Dividend Investors Looking for an Edge? 3 Stocks Insiders Bought Toyota Supercharges Joby: $250M Capital Infusion Ignites Stock Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
